Drug Shortage Report for TIMOLOL MALEATE-EX

Last updated on 2021-09-14 History
Report ID 94633
Drug Identification Number 02242275
Brand name TIMOLOL MALEATE-EX
Common or Proper name TIMOLOL
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) TIMOLOL
Strength(s) 0.25%
Dosage form(s) SOLUTION (EXTENDED RELEASE)
Route of administration OPHTHALMIC
Packaging size 5ml
ATC code S01ED
ATC description ANTIGLAUCOMA PREPARATIONS AND MIOTICS
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2019-09-02
Estimated end date 2021-09-17
Actual end date 2021-09-13
Shortage status Resolved
Updated date 2021-09-14
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2019-09-25 English Compare
v2 2019-09-25 English Compare
v3 2019-09-25 French Compare
v4 2019-10-15 English Compare
v5 2019-10-15 French Compare
v6 2019-12-10 English Compare
v7 2019-12-10 French Compare
v8 2020-02-12 English Compare
v9 2020-02-12 French Compare
v10 2020-05-04 English Compare
v11 2020-05-04 French Compare
v12 2020-11-27 English Compare
v13 2020-11-27 French Compare
v14 2021-01-25 English Compare
v15 2021-01-25 French Compare
v16 2021-02-08 English Compare
v17 2021-02-08 French Compare
v18 2021-04-27 English Compare
v19 2021-04-27 French Compare
v20 2021-06-21 English Compare

Showing 1 to 20 of 28